<DOC>
	<DOCNO>NCT03072381</DOCNO>
	<brief_summary>The propose project first assess pain- function-dependent , elbow-specific quality life in-vivo mechanical property common extensor tendon post-treatment PRP Level 1 , RCT subject assessor blinding . The valuable data gain significantly add knowledge base treatment effect PRP chronic tendinopathy . Positive finding PRP compare control ( corticosteroid injection ) would suggest future large scale study help establish optimal protocol nonsurgical management CLE . Correlating US shear wave acoustoelastography image assessment validate clinical outcome provide powerful tool future outcomes analysis use non-invasive imaging modality monitor tissue heal morphologically well biomechanically , may even use evaluate injury risk .</brief_summary>
	<brief_title>PEAK Platelet Rich Plasma Injection Treatment Chronic Lateral Epicondylosis</brief_title>
	<detailed_description>Randomization procedure Subjects randomize 1 2 study arm . Subjects Group 1 ( PRP ) receive single ultrasound-guided intratendinous ( common extensor tendon origin ) injection 3 mL autologous PEAK platelet-rich plasma week 0 ( baseline ) . Subjects Group 2 ( corticosteroid control ) receive single ultrasound-guided intratendinous injection approximately ( may limit tendon/soft tissue limitation subject ) 2 mL 1 % lidocaine + 1mL 40mg Kenalog ( triamcinolone hexacetonide , 40mg/mL ) week 0 . If subject bilateral elbow common extensor tendon pain , elbow treat study arm . Blinding : Subjects assessor blind subject group allocation . Control subject also undergo phlebotomy maintain blinding . Injection syringe cloak use opaque adhesive tape order ensure injector unaware subject treatment allocation . Subjects identify study personnel use unique study number result image study blind , batch evaluate randomized manner . Ultrasound image analysis conduct baseline , 26 week , 52 week post treatment . The platelet concentration analyze sample ( whole blood compare PRP ) order record verify consistency concentration factor PRP . Shear wave ultrasound imaging compare use comparison average shear wave speed ( SWS ) baseline post treatment 52 week follow-up two randomized group . Shear wave speed quantitative measure obtain measure speed ultrasound select region interest ( ROI ) . In prior study , study team successfully blind investigator select ROI , conduct inter-rater repeatability analysis show valid , repeatable way measure SWS particular ROI . For patient : Total 9 visit Initial Screen - Initial Eligibility Screening Baseline - Informational Meeting : Secondary eligibility screen , enrollment ( informed consent ) , questionnaires ; Grip Strength Test ; Ultrasound SWAE image Week 0 Intervention - Injection PRP ultrasound Weeks 4 , 8 , 12 , 16 - Questionnaires : QUICK-DASH , SF-12 , PRTEE , SANE-ELBOW , PRP Satisfaction ; Grip Strength Test Week 26 - Questionnaires : QUICK-DASH , SF-12 , PRTEE , SANE-ELBOW , PRP Satisfaction ; Grip Strength Test ; Ultrasound SWAE image Week 52 - Questionnaires : QUICK-DASH , SF-12 , PRTEE , SANE-ELBOW , PRP Satisfaction ; Grip Strength Test ; Ultrasound SWAE image</detailed_description>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>1. age 1865 2. chronic ( &gt; 3months ) unilateral bilateral common extensor tendon pain 3. clinical exam finding consistent CLE 4. image confirmation CLE ( U/S MRI ) 5. selfreported failure supervise physical therapy ; 6 ) selfreported failure least 2 common treatment ( NSAIDs , relative rest , ice , brace ) CLE . 1. inability comply followup requirement study 2. history bleeding disorder , lowplatelet count , hematologic condition 3. elbow pain possible etiology ( e.g. , degenerative joint disease ) 4. currently use anticoagulation immunosuppressive therapy 5. anticoagulant immunosuppressive therapy within prior month 6. know allergy Lidocaine 7. selfreported pregnancy 8. worker 's compensation injury 9. pending litigation 10. concurrent opioid use pain 11. corticosteroid injection within past 3 month 12. minor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>CLE</keyword>
	<keyword>epicondylosis</keyword>
	<keyword>platelet rich plasma</keyword>
	<keyword>PRP</keyword>
	<keyword>ultrasound</keyword>
	<keyword>shear wave ultrasound</keyword>
	<keyword>tendinopathy</keyword>
	<keyword>elbow</keyword>
	<keyword>tenis elbow</keyword>
	<keyword>plasma</keyword>
	<keyword>plasma injection</keyword>
	<keyword>tendinosis</keyword>
	<keyword>tendinitis</keyword>
</DOC>